Pharma Focus Asia

Aragen Invests US$30 million to Construct Bio-manufacturing Site in India

Aragen plans to invest US$30 million to setup a new biologics manufacturing facility in Bangalore, India.

The state-of-the-art facility, spanning an impressive area of nearly 160,000 square metres, is an extensive complex designed to cater to a wide range of biologics manufacturing needs. 

This facility boasts a range of critical components, including process development laboratories, multiple GMP manufacturing suites, and essential supporting functions such as quality control labs for both analytical and microbiology purposes.

The manufacturing suites within this cutting-edge facility have been purposefully equipped to enable intensified processing, employing single-use bioreactors and advanced downstream purification capabilities. 

This facility is set to offer an all-encompassing suite of services, covering everything from process development and validation to analytical development, pilot production, large-scale DS (Drug Substance) manufacturing, and stability services. 

It has the capacity and expertise to develop and manufacture a variety of biologics, including monoclonal antibodies (mAbs), therapeutic proteins, and fusion proteins, thereby bolstering its bioproduction capabilities in California.

Furthermore, this facility is designed to include plasmid DNA, mRNA, cell and gene therapy manufacturing, and additional GMP manufacturing suites as demand continues to grow.

The process development laboratory is projected to become operational by the third quarter of 2024, while the first manufacturing suite is scheduled to open in the third quarter of fiscal year 2025. 


Name      Aragen
Type        New Construction
Budget    US$30 million
Year        2025

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference